Jessica Snow - 06 Jan 2025 Form 4 Insider Report for 2seventy bio, Inc. (TSVT)

Role
Title: Senior Vice President of Quality and Enabling Functions
Signature
/s/ Iya Kessler, Attorney-in-Fact
Issuer symbol
TSVT
Transactions as of
06 Jan 2025
Net transactions value
$0
Form type
4
Filing time
08 Jan 2025, 18:51:09 UTC
Previous filing
22 Jan 2025
Next filing
19 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSVT Common Stock Award $0 +106,150 +72% $0.000000 253,329 06 Jan 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TSVT Stock Option (Right to buy) Award $0 +70,750 $0.000000 70,750 06 Jan 2025 Common Stock 70,750 $2.64 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This restricted stock unit award vests ratably over a four-year period in annual installments with the first installment vesting on January 2, 2026, subject to the Reporting Person's continued service through the applicable vesting date.
F2 This stock option vests over a four-year period at the rate of 25% on January 2, 2026, and then in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Remarks:

Title: Senior Vice President of Quality and Enabling Functions